Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
49.5M
-
Shares change
-
+3.82M
-
Total reported value, excl. options
-
$4.67B
-
Value change
-
+$407M
-
Put/Call ratio
-
0.59
-
Number of buys
-
142
-
Number of sells
-
-74
-
Price
-
$94.33
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2019
263 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2019.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.5M shares
of 62.5M outstanding shares and own 79.24% of the company stock.
Largest 10 shareholders include FMR LLC (7.15M shares), VANGUARD GROUP INC (4.28M shares), BlackRock Inc. (4.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.68M shares), WELLINGTON MANAGEMENT GROUP LLP (2.74M shares), Invesco Ltd. (1.8M shares), STATE STREET CORP (1.64M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (1.5M shares), PERCEPTIVE ADVISORS LLC (1.21M shares), and ALLIANCEBERNSTEIN L.P. (1.04M shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.